BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21623205)

  • 1. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
    Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
    Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
    Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
    Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
    Aximu D; Azad A; Ni R; Colgan T; Nanji S
    Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
    Pavlakis K; Messini I; Athanassiadou S; Kyrodimou E; Pandazopoulou A; Vrekoussis T; Stathopoulos EN
    Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
    Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
    Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix.
    Lu X; Shiozawa T; Nakayama K; Toki T; Nikaido T; Fujii S
    Int J Gynecol Pathol; 1999 Apr; 18(2):109-14. PubMed ID: 10202666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
    Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
    Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
    Badr RE; Walts AE; Chung F; Bose S
    Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
    Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
    Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of the study of the expression of MIB-1 (Ki-67) for the diagnosis of endocervical glandular lesions].
    Leteurtre E; Boman F; Farine MO; Leroy JL; Gosselin B
    Ann Pathol; 1998 Jul; 18(3):172-7. PubMed ID: 9706342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
    Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P16 as a molecular biomarker of cervical adenocarcinoma.
    Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
    Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.